US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 73.080
  • +1.980+2.78%
Close Apr 23 16:00 ET
3.46BMarket Cap-13867P/E (TTM)

Axsome Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
94.58M
50.04M
24.37M
16.85M
8.82M
0
Operating revenue
440.80%270.6M
193.50%71.53M
243.07%57.79M
429.48%46.7M
--94.58M
--50.04M
--24.37M
--16.85M
--8.82M
--0
Cost of revenue
401.44%26.07M
222.04%7.38M
239.50%6.53M
367.85%4.6M
7.56M
5.2M
2.29M
1.92M
983K
0
Gross profit
445.36%244.54M
190.54%64.15M
243.53%51.26M
437.21%42.1M
87.02M
44.84M
22.08M
14.92M
7.84M
0
Operating expense
93.12%427.44M
53.24%119.22M
97.93%113.56M
111.17%101.11M
144.34%93.56M
77.49%221.34M
138.58%77.8M
71.75%57.38M
55.21%47.88M
37.51%38.29M
Selling and administrative expenses
102.90%323.12M
41.16%86.81M
103.43%83.19M
153.32%78.94M
188.64%74.19M
138.96%159.25M
226.66%61.5M
102.17%40.89M
90.65%31.16M
128.51%25.7M
Research and development costs
69.02%97.94M
109.64%30.8M
93.37%28.77M
30.33%20.58M
41.38%17.79M
-0.20%57.95M
6.61%14.69M
12.87%14.88M
8.89%15.79M
-24.17%12.59M
Depreciation amortization depletion
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
--4.14M
--1.61M
--1.61M
--926K
--0
-Depreciation and amortization
54.02%6.38M
0.00%1.61M
0.00%1.61M
71.60%1.59M
--1.57M
--4.14M
--1.61M
--1.61M
--926K
--0
Operating profit
-3.63%-182.91M
1.17%-55.07M
-46.75%-62.3M
-47.36%-59M
82.93%-6.54M
-41.53%-176.5M
-70.87%-55.72M
-27.08%-42.45M
-29.80%-40.04M
-37.51%-38.29M
Net non-operating interest income expense
12.02%-6.45M
46.94%-702K
68.60%-757K
-20.96%-2.73M
-68.58%-2.26M
-28.77%-7.34M
3.29%-1.32M
-63.40%-2.41M
-57.12%-2.26M
5.15%-1.34M
Non-operating interest expense
-12.02%6.45M
-46.94%702K
-68.60%757K
20.96%2.73M
68.58%2.26M
28.77%7.34M
-3.29%1.32M
63.40%2.41M
57.12%2.26M
--1.34M
Other net income (expense)
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
162K
-3.3M
-4.2M
42K
860K
Special income (charges)
-1,383.26%-48.92M
-928.74%-43.21M
328.57%180K
-803.84%-6.05M
--162K
---3.3M
---4.2M
--42K
--860K
--0
-Less：Restructuring and merger&acquisition
1,383.26%48.92M
928.74%43.21M
-328.57%-180K
803.84%6.05M
---162K
--3.3M
--4.2M
---42K
---860K
--0
Income before tax
-27.33%-238.28M
-61.62%-98.98M
-40.28%-62.88M
-63.59%-67.79M
78.20%-8.64M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
-28.35%-41.44M
-35.45%-39.63M
Income tax
960K
-325K
-678K
-617K
2.58M
0
0
0
0
0
Net income
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
-28.35%-41.44M
-35.45%-39.63M
Net income continuous Operations
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
-28.35%-41.44M
-35.45%-39.63M
Minority interest income
Net income attributable to the parent company
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
-28.35%-41.44M
-35.45%-39.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-27.84%-239.24M
-61.09%-98.65M
-38.77%-62.2M
-62.10%-67.17M
71.69%-11.22M
-43.50%-187.13M
-80.25%-61.24M
-28.50%-44.82M
-28.35%-41.44M
-35.45%-39.63M
Basic earnings per share
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
-32.56%-4.6
-56.67%-1.41
-15.05%-1.07
-23.26%-1.06
-32.05%-1.03
Diluted earnings per share
-14.57%-5.27
-47.52%-2.08
-23.36%-1.32
-45.28%-1.54
74.76%-0.26
-32.56%-4.6
-56.67%-1.41
-15.05%-1.07
-23.26%-1.06
-32.05%-1.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M94.58M50.04M24.37M16.85M8.82M0
Operating revenue 440.80%270.6M193.50%71.53M243.07%57.79M429.48%46.7M--94.58M--50.04M--24.37M--16.85M--8.82M--0
Cost of revenue 401.44%26.07M222.04%7.38M239.50%6.53M367.85%4.6M7.56M5.2M2.29M1.92M983K0
Gross profit 445.36%244.54M190.54%64.15M243.53%51.26M437.21%42.1M87.02M44.84M22.08M14.92M7.84M0
Operating expense 93.12%427.44M53.24%119.22M97.93%113.56M111.17%101.11M144.34%93.56M77.49%221.34M138.58%77.8M71.75%57.38M55.21%47.88M37.51%38.29M
Selling and administrative expenses 102.90%323.12M41.16%86.81M103.43%83.19M153.32%78.94M188.64%74.19M138.96%159.25M226.66%61.5M102.17%40.89M90.65%31.16M128.51%25.7M
Research and development costs 69.02%97.94M109.64%30.8M93.37%28.77M30.33%20.58M41.38%17.79M-0.20%57.95M6.61%14.69M12.87%14.88M8.89%15.79M-24.17%12.59M
Depreciation amortization depletion 54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M--4.14M--1.61M--1.61M--926K--0
-Depreciation and amortization 54.02%6.38M0.00%1.61M0.00%1.61M71.60%1.59M--1.57M--4.14M--1.61M--1.61M--926K--0
Operating profit -3.63%-182.91M1.17%-55.07M-46.75%-62.3M-47.36%-59M82.93%-6.54M-41.53%-176.5M-70.87%-55.72M-27.08%-42.45M-29.80%-40.04M-37.51%-38.29M
Net non-operating interest income expense 12.02%-6.45M46.94%-702K68.60%-757K-20.96%-2.73M-68.58%-2.26M-28.77%-7.34M3.29%-1.32M-63.40%-2.41M-57.12%-2.26M5.15%-1.34M
Non-operating interest expense -12.02%6.45M-46.94%702K-68.60%757K20.96%2.73M68.58%2.26M28.77%7.34M-3.29%1.32M63.40%2.41M57.12%2.26M--1.34M
Other net income (expense) -1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M162K-3.3M-4.2M42K860K
Special income (charges) -1,383.26%-48.92M-928.74%-43.21M328.57%180K-803.84%-6.05M--162K---3.3M---4.2M--42K--860K--0
-Less：Restructuring and merger&acquisition 1,383.26%48.92M928.74%43.21M-328.57%-180K803.84%6.05M---162K--3.3M--4.2M---42K---860K--0
Income before tax -27.33%-238.28M-61.62%-98.98M-40.28%-62.88M-63.59%-67.79M78.20%-8.64M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M-28.35%-41.44M-35.45%-39.63M
Income tax 960K-325K-678K-617K2.58M00000
Net income -27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M-28.35%-41.44M-35.45%-39.63M
Net income continuous Operations -27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M-28.35%-41.44M-35.45%-39.63M
Minority interest income
Net income attributable to the parent company -27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M-28.35%-41.44M-35.45%-39.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -27.84%-239.24M-61.09%-98.65M-38.77%-62.2M-62.10%-67.17M71.69%-11.22M-43.50%-187.13M-80.25%-61.24M-28.50%-44.82M-28.35%-41.44M-35.45%-39.63M
Basic earnings per share -14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26-32.56%-4.6-56.67%-1.41-15.05%-1.07-23.26%-1.06-32.05%-1.03
Diluted earnings per share -14.57%-5.27-47.52%-2.08-23.36%-1.32-45.28%-1.5474.76%-0.26-32.56%-4.6-56.67%-1.41-15.05%-1.07-23.26%-1.06-32.05%-1.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg